Effectiveness of SMS-text Message Support for Patients With Hypertension to Improve Blood Pressure
*StAR
SMS-text Adherence Support (StAR*) Study, a Randomized Three-arm Open Parallel Group Trial to Evaluate the Effects of a Structured Programme of Hypertension Treatment Adherence Support Delivered Remotely Through SMS-text Messages on Blood Pressure at 12 Months as Compared With Usual Care.
4 other identifiers
interventional
1,372
0 countries
N/A
Brief Summary
General synopsis for SMS-text Adherence Support (\*StAR) Study and associated preparatory and pilot work Background: High blood pressure is an important risk factor for heart disease, stroke and chronic kidney disease. Clear evidence exists that for individuals with high blood pressure (hypertension) lowering blood pressure really reduces this risk. One of the critical factors in the long term control of blood pressure is the regular use of effective antihypertensive medications. In South Africa, poor treatment adherence (attending clinic, re-filling prescriptions, and regularly taking hypertension tablets) is known to be an important and alterable risk factor for uncontrolled high blood pressure and its complications (heart disease, stroke and chronic kidney disease). SMS-text messages have been shown to improve clinic attendance and medication adherence for some diseases (like HIV and TB) in other low-resource settings. It is not clear whether SMS-text messages to support treatment adherence have an effect on long-term blood pressure control. The acceptability, sustainability and scalability such technology also remains to be determined. Aim: To investigate if a system of SMS-text messages to support treatment adherence is more effective than usual care for controlling high blood-pressure. Objectives: The main objective is to test whether advice and support given by SMS-text, either by providing information (informational) or by allowing a two-way communication (interactive) improves control of blood pressure at one year compared to usual care. Additional objectives include assessing whether the interventions have an effect on,
- Clinic attendance
- Prescription refill adherence
- Self-reported medication adherence
- Hypertension related illness or death
- Patient empowerment Study design: Single centre randomized three-arm parallel group trial As it is not clear how best to support treatment adherence for people with hypertension we need to compare the different ways this might be done. Eligible patients who provide written consent will be put into one of three groups and then compared. The groups are selected by a computer which has no information about the individual (i.e. by chance). Participants in each group will get different types of SMS-text messages and these are compared. Study interventions:
- Enhanced usual care In addition to their usual clinical care participants will receive the pre-randomisation "Welcome to the \*StAR Study" SMS-text, a "Happy Birthday" SMS-text on their date of birth and up to six additional SMS-text messages containing study specific information and thanking the participant for taking part in the study.
- Informational SMS-text messages In addition to enhanced usual care, participants allocated to the informational SMS-text support group will receive semi-tailored structured adherence-support (including clinic appointment and medication pick-up reminders, medication adherence support and hypertension-related education.)
- Interactive SMS-text messages In addition to enhanced usual care and informational SMS-text messages, SMS-text messages sent to participants in the interactive SMS-text group will contain a "prompt to respond" which will guide participants to additional SMS-text based resources. Outcome measures: The main outcome measure is mean blood pressure measured at one year. Additional outcomes include the proportion of participants with "controlled blood pressure" as well as measures of clinic attendance, prescription refill adherence, self-reported medication adherence, hypertension related illness or death, and patient empowerment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jun 2012
Typical duration for not_applicable hypertension
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 18, 2013
CompletedFirst Posted
Study publicly available on registry
December 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedNovember 11, 2014
November 1, 2014
1.7 years
December 18, 2013
November 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in systolic blood pressure
The primary outcome is change in systolic blood pressure which we will analyse using a mixed-effects model on data collected at 6 and 12-months.
12-months from baseline
Secondary Outcomes (1)
Measured treatment adherence
3-monthly intervals over 12-months of follow-up
Other Outcomes (7)
Proportion of participants with a systolic blood pressure < 140 mmHg and a diastolic blood pressure <90 mmHg
At 12-months
Hospital admissions for hypertension related illnesses
At 12-months
Self-reported health status
At 12-months
- +4 more other outcomes
Study Arms (3)
Enhanced usual care
ACTIVE COMPARATORIn addition to usual care participants will receive the pre-randomisation "Welcome to the \*StAR Study" SMS-text, post-randomisation they will received a "Happy Birthday" SMS-text on their date of birth and up to six additional SMS-text messages containing study specific information and thanking the participant for taking part in the study. Participants in the Enhanced Usual Care group will receive no more than one study specific SMS-text every two months.
Informational SMS-text
EXPERIMENTALIn addition to enhanced usual care, participants allocated to the informational SMS-text support group will receive a series of text-messages covering the following areas: I. Medication pick-up reminders send 48 hours before scheduled medication pick-up date a) Participants who fail to pick-up medication within 3 days of scheduled pick-up date will be sent one further reminder SMS-text II. III. Clinic appointment reminder 48 hours before scheduled follow-up appointment a) Participants who fail to attend clinic appointment will be sent an additional SMS-text checking they are alright and inviting them to rebook their appointment via the clinic IV. Messages which support medication adherence (focused on organisation, memory, and habit) or provide hypertension related health information
Interactive SMS-text
EXPERIMENTALIn addition to enhanced usual care and informational SMS-text messages, SMS-text messages sent to participants in the interactive SMS-text group will contain a "prompt to respond" which will guide participants to additional SMS-text based resources.
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of hypertension and are either currently receiving or are about to start blood pressure lowering medication
- Mean blood pressure at enrolment is \< 175/105
- Aged 21 years or older
- Must have access to a cell-phone (shared access is allowed if access is daily and the phone owner agrees to participate)
- Must be able to use SMS-text (help by a partner is allowed for illiterate subjects, subjects with poor vision, or subjects who are learning disabled)
- Must be resident in the study area and must be expected to be resident for the duration of the study
You may not qualify if:
- Another member of the household has already been recruited into the trial
- If female, they are not pregnant or within three months post-partum by self-report
- They are not willing to give informed consent and take part in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- Wellcome Trustcollaborator
- EPSRCcollaborator
- University of Cape Towncollaborator
Related Publications (4)
Bobrow K, Brennan T, Springer D, Levitt NS, Rayner B, Namane M, Yu LM, Tarassenko L, Farmer A. Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial. BMC Public Health. 2014 Jan 11;14:28. doi: 10.1186/1471-2458-14-28.
PMID: 24410738BACKGROUNDBobrow K, Farmer A, Cishe N, Nwagi N, Namane M, Brennan TP, Springer D, Tarassenko L, Levitt N. Using the Medical Research Council framework for development and evaluation of complex interventions in a low resource setting to develop a theory-based treatment support intervention delivered via SMS text message to improve blood pressure control. BMC Health Serv Res. 2018 Jan 23;18(1):33. doi: 10.1186/s12913-017-2808-9.
PMID: 29361934DERIVEDBobrow K, Farmer AJ, Springer D, Shanyinde M, Yu LM, Brennan T, Rayner B, Namane M, Steyn K, Tarassenko L, Levitt N. Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial. Circulation. 2016 Feb 9;133(6):592-600. doi: 10.1161/CIRCULATIONAHA.115.017530. Epub 2016 Jan 14.
PMID: 26769742DERIVEDLeon N, Surender R, Bobrow K, Muller J, Farmer A. Improving treatment adherence for blood pressure lowering via mobile phone SMS-messages in South Africa: a qualitative evaluation of the SMS-text Adherence SuppoRt (StAR) trial. BMC Fam Pract. 2015 Jul 3;16:80. doi: 10.1186/s12875-015-0289-7.
PMID: 26137844DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lionel Tarassenko, MA, DPhil, FREng, FIET
University of Oxford
- PRINCIPAL INVESTIGATOR
Andrew Farmer, DM FRCGP
University of Oxford
- PRINCIPAL INVESTIGATOR
Naomi Levitt, MBChB, MD and FCP(SA))
University of Cape Town
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2013
First Posted
December 24, 2013
Study Start
June 1, 2012
Primary Completion
February 1, 2014
Study Completion
August 1, 2014
Last Updated
November 11, 2014
Record last verified: 2014-11